Search Results - "Zhou, Zhengcan"

  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    Biomarkers in heart failure: the past, current and future by Sarhene, Michael, Wang, Yili, Wei, Jing, Huang, Yuting, Li, Min, Li, Lan, Acheampong, Enoch, Zhengcan, Zhou, Xiaoyan, Qin, Yunsheng, Xu, Jingyuan, Mao, Xiumei, Gao, Guanwei, Fan

    Published in Heart failure reviews (01-11-2019)
    “…Despite the enhanced knowledge of the pathophysiology of heart failure (HF), it still remains a serious syndrome with substantial morbidity, mortality, and…”
    Get full text
    Journal Article
  2. 2

    Qi Dan Li Xin pill improves chronic heart failure by regulating mTOR/p70S6k-mediated autophagy and inhibiting apoptosis by Shi, Binhao, Huang, Yuting, Ni, Jingyu, Chen, Jingrui, Wei, Jing, Gao, Hui, Li, Lan, Zhou, Zhengcan, Wang, Yili, Xu, Yunsheng, Xu, Zongpei, Mao, Jingyuan, Fan, Guanwei

    Published in Scientific reports (08-04-2020)
    “…Myocardial remodeling represents a key factor in chronic heart failure (CHF) development, and is characterized by chronic death of cardiomyocytes. Cardiac…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Network Pharmacology-Guided Development of a Novel Integrative Regimen to Prevent Acute Graft-vs.-Host Disease by Lyu, Ming, Zhou, Zhengcan, Wang, Xiaoming, Lv, Hong, Wang, Mei, Pan, Guixiang, Wang, Yuefei, Fan, Guanwei, Gao, Xiumei, Feng, Yuxin, Zhu, Yan

    Published in Frontiers in pharmacology (13-12-2018)
    “…Lapses in the graft-vs.-host disease (GVHD) prophylaxis and side effects of current standard care following allogeneic hematopoietic stem cell transplantation…”
    Get full text
    Journal Article
  5. 5

    Protecting Intestinal Microenvironment Alleviates Acute Graft-Versus-Host Disease by Zhou, Zhengcan, Shang, Ting, Li, Xiurong, Zhu, Hongyan, Qi, Yu-Bo, Zhao, Xin, Chen, Xi, Shi, Zhe-Xin, Pan, Guixiang, Wang, Yue-Fei, Fan, Guanwei, Gao, Xiumei, Zhu, Yan, Feng, Yuxin

    Published in Frontiers in physiology (12-02-2021)
    “…Acute gut graft-versus-host disease (aGVHD) is a leading threat to the survival of allogeneic hematopoietic stem cell transplantation (allo-HSCT) recipients…”
    Get full text
    Journal Article